HVH Precision Analytics and Diligentia Strategy Announce Upcoming Presentation at the 2020 American

New research on the use of claims data for gene therapy trials will be presented by HVH Precision Analytics and Diligentia Strategy during the upcoming 2020 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting (May 12-15, 2020). This poster presentation will take place virtually during the Cancer – Targeted Gene and Cell Therapy Session on Wednesday, May 13, 2020. The full abstract is now available online. “We’re excited to show that the application of machine learning approaches, combined with data science expertise and a deep understanding of rare diseases, can accelerate the process of identifying eligible patients for clinical trial recruitment and the launch of new drugs and

Recent Posts
  • LinkedIn Social Icon

© 2019 Diligentia LLC

(202) 744-0755